The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-ß- catenin signaling axis.
Oncotarget
; 8(13): 21754-21769, 2017 Mar 28.
Article
in En
| MEDLINE
| ID: mdl-28423516
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Adenocarcinoma
/
Signal Transduction
/
Antineoplastic Combined Chemotherapy Protocols
/
Celecoxib
/
Cetuximab
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2017
Document type:
Article
Affiliation country:
Spain
Country of publication:
United States